XML 20 R6.htm IDEA: XBRL DOCUMENT v3.20.2
Consolidated Statements of Cash Flows - USD ($)
6 Months Ended
Jun. 30, 2020
Jun. 30, 2019
CASH FLOWS FROM OPERATING ACTIVITIES:    
Net loss $ (20,652,565) $ (5,484,194)
Adjustments to reconcile net loss to net cash used in operating activities:    
Change in fair value of contingent consideration 13,640,000  
Stock-based compensation expense 545,431 697,486
Depreciation 120,169 121,899
Amortization 25,876 107,580
Unrealized losses (gains) on foreign currency exchange (18,851) (24,943)
Changes in fair value of warrant liability   46,000
Changes in operating assets and liabilities:    
Accounts receivable (160,920) 832,098
Prepaid expenses and other current assets (343,337) (113,200)
Accounts payable 176,985 (102,763)
Accrued expenses and other liabilities 26,761 (1,181,457)
Tax refund receivable (4,877,851) (71,586)
Net cash used in operating activities (11,518,302) (5,173,080)
CASH FLOWS FROM INVESTING ACTIVITIES:    
Proceeds from sales and maturities of short-term investments 24,900,000  
Purchases of short-term investments (12,118,563)  
Purchase of property and equipment (40,601) (1,226)
Cash paid for internally developed patents (79,336) (15,874)
Net cash provided by (used in) investing activities 12,661,500 (17,100)
CASH FLOWS FROM FINANCING ACTIVITIES:    
Payments of deferred offering costs (179,743)  
Proceeds from exercises of warrants 31,310,137 30,324
Proceeds from issuance of common stock in at the market offering, net of offering costs 22,780,729  
Proceeds from issuance of common units, net of issuance costs   12,668,784
Proceeds from issuance of notes payable 632,000  
Proceeds from issuance of common stock from Employee Stock Purchase Plan 56,739  
Proceeds from exercises of stock options 36,175  
Payments of notes payable   (156,145)
Net cash provided by financing activities 54,636,037 12,542,963
Net increase in cash and cash equivalents and restricted cash 55,779,235 7,352,783
Cash, cash equivalents and restricted cash at beginning of period 8,996,860 34,353,129
Cash, cash equivalents and restricted cash at end of period $ 64,776,095 $ 41,705,912